OLD Category: signatures

September 17, 2021 / Nat Commun

  • Crouchet E, Bandiera S, Fujiwara N...Fuchs BC, Hoshida Y, Baumert TF
September 17, 2021 / Evid Based Complement Alternat Med

  • Jantaravinid J, Jiamton S, Srisawat C, Suktitipat B, Tirawanchai N
September 16, 2021 / Sci Rep

  • Kramer Z, Kenessey I, Gango A, Lendvai G, Kulka J, Tokes AM
September 16, 2021 / PLoS One

  • Saraji A, Offermann A, Stegmann-Frehse J...Kirfel J, Perner S, Sailer V
September 15, 2021 / Breast Cancer Res Treat

  • Haynes BP, Schuster G, Buus R...Cleator SJ, Smith IE, Dowsett M
September 15, 2021 / Cancers (Basel)

  • Carpenter S, Conlan RS
September 15, 2021 / Front Immunol

  • Rad HS, Röhl J, Stylianou N, Allenby MC, Bazaz SR, Warkiani ME, Guimaraes FSF, Clifton VL, Kulasinghe A
September 15, 2021 / Nat Commun

  • Schmitz R, Fitch ZW, Schroder PM...Lambris JD, Kwun J, Knechtle SJ
September 14, 2021 / Nicotine Tob Res

  • Davis ES, Ghosh A, Coakley RD...Alexis NE, Ribeiro CMP, Tarran R
September 13, 2021 / Cancer Res

  • Evans KW, Yuca E, Scott SS...Heffernan TP, Marszalek JR, Meric-Bernstam F
September 13, 2021 / Nat Commun

  • Bakhoum MF, Francis JH, Agustinus A...Mischel PS, Bakhoum SF, Laughney AM
September 11, 2021 / Cancers (Basel)

  • Kirfel J, Kümpers CC, Fähnrich A...Offermann A, Busch H, Perner S